Page last updated: 2024-11-05

trifluoperazine and Cardiotoxicity

trifluoperazine has been researched along with Cardiotoxicity in 1 studies

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Goda, AE1
Elenany, AM1
Elsisi, AE1

Other Studies

1 other study available for trifluoperazine and Cardiotoxicity

ArticleYear
Novel in vivo potential of trifluoperazine to ameliorate doxorubicin-induced cardiotoxicity involves suppression of NF-κB and apoptosis.
    Life sciences, 2021, Oct-15, Volume: 283

    Topics: Animals; Apoptosis; Cardiotoxicity; Cardiotoxins; Caspase 3; Doxorubicin; Male; Mice; Myocardium; Tr

2021